Board Name | Posts By geoffwe | Post Created |
---|---|---|
MYDX MyDx, Inc. | Love the 8k! Go MYDX! | 06/16/2017 10:50:38 AM |
Recent Articles
- Deep Dive into P/E Ratios of PTC Inc. Stocks
- GT Biopharma's Growth Momentum and Strong Financial Performance
- WallachBeth Capital Completes Successful Funding for BioAffinity
- Harrow's Bullish Options Activity and Market Insights
- Elah Holdings, Inc. Unveils Second Quarter Financials
- Profound Medical Via AI Technology: Q2 Results and Future Growth
- Understanding Recent Investment Trends for Fair Isaac Corp.
- TOMI Environmental Solutions Reveals Financial Success and Future Plans
- Understanding Pinterest's Recent Options Activity Trends
- Exploring the Profits of Investing in Royal Caribbean Group
- Century Aluminum: Capitalizing on Domestic Manufacturing Trends
- Investor Sentiment Analysis of Live Nation Entertainment
- authID Achieves Record Quarterly Revenue and Growth Signals
- How Micron Technology's Strategic Vision Drives Stock Optimism
- Evaluating SoFi Technologies: Market Trends and Short Interest Insights
- Insights on Taiwan Semiconductor's Short Selling Activity
- Glucotrack's Latest Advances and Financial Performance Overview
- E-Mini S&P 500: Navigating the Battle Lines Ahead
- SL Green Realty Corp. Engages at Major Real Estate Conference
- AuthID Celebrates Record Revenue and Growth in Q2 2025 Results
- Venus Concept Shows Improvement in Q2 2025 Performance Metrics
- CapsoVision's Positive Growth: A 2025 Financial Overview
- Dragonfly Energy’s Q2 2025 Performance Exceeds Expectations
- Intchains Group Limited's ETH Strategy and Financial Update
- Nasus Pharma's IPO: Paving the Way for Innovative Treatments
- TILT Holdings Shares Insights on Q2 2025 Performance
- Bolt Biotherapeutics Unveils Q2 2025 Financial Highlights
- TOMI Environmental Solutions Achieves Remarkable Q2 Growth
- Magnite's Upcoming Financial Conferences and Insights
- Fortress Biotech's Q2 2025 Achievements and Financial Insights
- IO Biotech's Q2 2025 Results: Advancements in Cancer Therapy
- Diginex and Resulticks Collaborate for Enhanced Solutions
- Elutia's Growth Journey: Driving Innovation and Success
- Shimmick Corporation's Strong Q2 2025 Financial Performance Revealed
- Talphera's Q2 Financials: Progress Despite Challenges Ahead
- Shuttle Pharma Updates Progress on Phase 2 Trial for Glioblastoma
- Martin Marietta Optimizes Cash Dividends to Boost Shareholder Value
- BioStem Technologies: Analyzing Q2 2025 Performance and Developments
- Discover the Magic of Evolved Spellbound on Star Princess
- Vuzix Shows Strength in Q2 2025 Earnings and Future Plans
- Exciting Insights from Motorsport Games' Upcoming Investor Event
- SUNation Energy Postpones Financial Results Release
- Starz Entertainment Reports Financial Growth Plans Ahead
- Opportunities for CTO Realty Growth, Inc. Investors Amid Lawsuit
- Cineverse Achieves Impressive Revenue Growth in Q1 FY 2026
- Quantum Computing Inc. Achieves Notable Growth in Q2 2025
- Co-Diagnostics, Inc. Reveals Q2 2025 Performance Updates
- Fortress Biotech Achieves Key Milestones and Financial Growth
- Shimmick Corporation Second Quarter Update: Growth and Strategy
- Workday Enhances Platform with Flowise Acquisition for AI Agents